{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:32:03Z","timestamp":1787772723009,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Therapeutic plasma exchange (TPE) has been advocated as an adjunct to steroids and cytotoxic drugs in treating patients suffering from vasculitis and presenting with active disease, but we still have insufficient evidence on its effectiveness in improving the clinical response, especially in India. This study was planned to study the clinical outcome in severe vasculitic presentations treated with TPE as an adjunctive therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>A retrospective analysis of TPE procedures performed from July 2013 to July 2017 in the department of transfusion medicine at a large tertiary care hospital was done. All consecutive patients admitted with new diagnosis of systemic vasculitis presenting with active disease and severe presentations such as advanced renal failure or severe respiratory abnormalities or life-threatening vasculitis affecting the gastrointestinal tract, neurological and musculoskeletal system; who needed TPE for removal of preformed antibodies, were included in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>There were a total of 31 patients in whom TPE was performed for severe systemic vasculitis; 26 adults and five pediatric. Six patients tested positive for perinuclear fluorescence, 13 for cytoplasmic fluorescence (cANCA), two for atypical antineutrophil cytoplasmic autoantibody, seven for anti-glomerular basement membrane antibodies, two for antinuclear antibodies (ANA), and one patient tested positive for ANA as well as cANCA before the augmentation of TPE. Out of 31, seven patients showed no clinical improvement and succumbed to the disease. At the end of desired number of procedures, 19 tested negative and five tested weak positive for their respective antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Favorable clinical outcomes were observed with TPE in patients with antibody-positive systemic vasculitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_50_21","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T10:32:53Z","timestamp":1725013973000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Patient outcome in antibody-positive systemic vasculitis treated with therapeutic plasma exchange"],"prefix":"10.4103","volume":"17","author":[{"given":"Aseem Kumar","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Setya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geet","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiva","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Bihari","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth Kumar","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20240830","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrneph.2012.107","article-title":"Complications of long-term therapy for ANCA-associated systemic vasculitis","volume":"8","author":"Wall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R2-14-20240830","doi-asserted-by":"crossref","first-page":"e3748","DOI":"10.1097\/MD.0000000000003748","article-title":"Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis","volume":"95","author":"Jarrot","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R3-14-20240830","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/1744-9987.12549","article-title":"Changing trends in therapeutic plasmapheresis: An Indian perspective","volume":"21","author":"Tiwari","year":"2017","journal-title":"Ther Apher Dial"},{"key":"R4-14-20240830","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ckj\/sfv084","article-title":"Plasma exchange for paediatric kidney disease-indications and outcomes: A single-centre experience","volume":"8","author":"Reddy","year":"2015","journal-title":"Clin Kidney J"},{"key":"R5-14-20240830","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s12098-012-0779-8","article-title":"Therapeutic plasmapheresis using membrane plasma separation","volume":"79","author":"Sinha","year":"2012","journal-title":"Indian J Pediatr"},{"key":"R6-14-20240830","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10157-013-0869-6","article-title":"Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"17","author":"Jennette","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"R7-14-20240830","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/thorax.55.10.870","article-title":"Churg-Strauss syndrome","volume":"55","author":"Conron","year":"2000","journal-title":"Thorax"},{"key":"R8-14-20240830","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","article-title":"Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups","volume":"61","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"R9-14-20240830","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R10-14-20240830","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/ndt\/gfh293","article-title":"Plasmapheresis with immunosuppressive therapy vs. immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis","volume":"19","author":"Nakamura","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R11-14-20240830","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","article-title":"Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies","volume":"40","author":"Pusey","year":"1991","journal-title":"Kidney Int"},{"key":"R12-14-20240830","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ndt\/gfq360","article-title":"Plasma exchange for induction and Cyclosporine A for maintenance of remission in Wegener's Granulomatosis \u2013 A clinical controlled, randomized trial","volume":"26","author":"Szpirt","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R13-14-20240830","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM199205213262101","article-title":"A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group","volume":"326","author":"Lewis","year":"1992","journal-title":"N Engl J Med"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.AJTS_50_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:10:28Z","timestamp":1787771428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.AJTS_50_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_50_21","relation":{},"ISSN":["0973-6247"],"issn-type":[{"value":"0973-6247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}